(Q43722434)

26 November 2017

title

Hepatocellular expression of a dominant-negative mutant TGF-beta type II receptor accelerates chemically induced hepatocarcinogenesis (English)

1 reference

26 November 2017

Kanzler S

1

1 reference

26 November 2017

Meyer E

2

1 reference

26 November 2017

Lohse AW

3

1 reference

26 November 2017

Schirmacher P

4

1 reference

26 November 2017

Henninger J

5

1 reference

26 November 2017

Galle PR

6

1 reference

26 November 2017

Blessing M

7

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

26 November 2017

number of pages

10

1 reference

inferred from page(s)

published in

Oncogene

1 reference

26 November 2017

volume

20

1 reference

26 November 2017

issue

36

1 reference

26 November 2017

page(s)

5015-5024

1 reference

Expression of a dominant negative type II TGF-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor beta 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

21 January 2018

TGF-beta and fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

Molecular cloning and characterization of TIEG2 reveals a new subfamily of transforming growth factor-beta-inducible Sp1-like zinc finger-encoding genes involved in the regulation of cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

Disruption of redox homeostasis in the transforming growth factor-alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

Structure and sequence of the mouse Bmp6 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

Growth inhibition by transforming growth factor beta (TGF-beta) type I is restored in TGF-beta-resistant hepatoma cells after expression of TGF-beta receptor type II cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

Tumor suppressor activity of the TGF-beta pathway in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

TGFbeta signaling in growth control, cancer, and heritable disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

The transforming growth factor beta(1)-inducible transcription factor TIEG1, mediates apoptosis through oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

Activin A regulates growth and acute phase proteins in the human liver cell line, HepG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

Induction of p53 and Bax during TGF-beta 1 initiated apoptosis in rat liver epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

Expression of a dominant-negative type II transforming growth factor beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF-beta-mediated growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

Isolation of human C-reactive protein complementary DNA and localization of the gene to chromosome 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

7 January 2021

Transforming growth factor—beta 1 (TGF-β1) and TGF-β1 receptors in normal, cirrhotic, and neoplastic human livers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

7 January 2021

Levels of transforming growth factor beta and transforming growth factor beta receptors in rat liver during growth, regression by apoptosis and neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

7 January 2021

Absence of TGF-beta receptors and growth inhibitory responses in retinoblastoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

7 January 2021

Alteration in growth regulation of hepatocytes in primary culture obtained from cirrhotic rat: poor response to transforming growth factor-beta 1 and interferons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

7 January 2021

Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

7 January 2021

Regulation of the human C-reactive protein gene in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

7 January 2021

Specificity, diversity, and regulation in TGF-beta superfamily signaling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

7 January 2021

Microsatellite instability in European hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

7 January 2021

Activation of caspase-8 in transforming growth factor-beta-induced apoptosis of human hepatoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

7 January 2021

Regulation of cell cycle-related genes in rat hepatocytes by transforming growth factor beta1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204544

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204544

1 reference

Dimensions Publication ID

26 November 2017

1013087526

0 references

1 reference